Supported by thirteen members of the Oncology State Societies at ACCC, the educational programs below were developed in response to critical issues in cancer care. Presentation were developed by an esteemed group of faculty, while Q&A discussions facilitate the sharing and exchange of ideas.
While recent developments may have been made for some of the topics below, these on-demand webinars serve as a convenient review for all members of the multidisciplinary cancer care team.
Plain & Simple: Strategies for Improving Health Literacy
Presented by: Elaine S. DeMeyer, RN, MSN, AOCN, Beyond Oncology
Although many cancer programs have made significant headway in providing patient-friendly materials, health literacy related to cancer diagnosis, treatment, and post-treatment follow-up requires on-going attention. This webinar will give you a deeper understanding of the importance of evaluating your cancer program's current health literacy efforts, identify areas where simple quality improvement measures can lead to more effective communication, and be introduced to an easy-to-implement gap assessment tool* that will help improve health literate communications throughout the cancer care continuum.
*This gap assessement tool is a product of the Association of Community Cancer Centers (ACCC) education project, Let's Be Clear: Communicating to Improve the Cancer Patient Experience. Additional health literacy resources may be found on the ACCC website here.
Biosimilars: An Overview
Presented by: Sandra Werking, PharmD, BCPS, Sandoz Pharmaceuticals
One complexity surrounding biosimilars lies in the essence of their variability. Learn from Sandy Werking, Sandoz Pharmaceuticals, as she explains the underpinnings of biologics. You’ll also get an overview of the FDA’s recently published draft guidelines for demonstrating biosimilar interchangeability and more!
Managing Your Patients’ Immune-Related Adverse Events (irAEs)
Presented by: Brianna Hoffner, MSN, NP, RN, University of Colorado, School of Medicine
As the spectrum of immune-related adverse events (irAEs) expands to include less common, albeit more severe manifestations, early detection becomes increasingly vital for patient safety and treatment tolerability. If diagnosed quickly and managed properly, most irAEs are reversible. Watch this webinar to gain a deeper understanding of this growing spectrum and learn how to effectively manage your patients’ irAEs using a multidisciplinary approach.
Creating Partnerships Between Oncology Nurse Navigators & Oncology Practices
Presented by: Tricia Strusowski, RN, MS, Oncology Solutions, LLC
Learn how cancer programs are successfully collaborating with nurse navigators to decrease admissions and emergency room visits, adhere to national guidelines, provide survivorship care plans, and deliver successful outcomes. The case studies presented in this webinar will demonstrate alignment with patient-centered, value-based models such as the Oncology Care Model (OCM) and more!
Adapting to USP <800> and What the Changes Will Mean for Oncology Practices
Presented by: Willis Triplett, PharmD, Comply797 and Comply800
Download this presentation for an overview of existing USP <800> regulations and standards, learn how new changes will impact your practice's care of hazardous drugs, and more
Steps to Success: Implementing Oral Oncolytics
Presented by: Peter Schlickman, PharmD, BCOP, Sarah Cannon Research Institute
Oral agents offer benefits to both patients and providers. Because patients self-administer oral anticancer drugs at home, travel to treatment and time spent in the cancer center or physician office can be reduced. However, oral therapies present challenges in terms of patient compliance with treatment regimens, monitoring of side effects, and the cost of treatment.
How to Navigate Patient Financial Toxicity
Presented by: Dan Sherman, MA, LPC, The NaVectis Group
Financial toxicity is one of the newest side effects of cancer care treatment for both patients and cancer programs. With a growing underinsured patient population and rising costs of care, the need to prepare patients for financial burdens is crucial. Benefit from the latest trends, effective practices, and strategies to better position your program to support patients as they deal with the financial issues surrounding cancer diagnosis and treatment.
Chemotherapy Safe Handling: What You Need to Know
Presented by: Martha (Marty) Polovich, PhD, RN, AOCN, Georgia State University
Explore the requirements and recommendations for safe chemotherapy handling to establish your own chemotherapy program or ensure your existing program is being managed as safely as possible.
Biosimilars: Implications for Medical Oncology
Presented by: George Silberman, The Cancer Policy Group, LLC
With the approval of the first biosimilar in March of 2015, questions regarding this new class of products—what they are, how they are regulated, how they are covered and reimbursement policies, and what implications they have for the quality and safety of care—have taken on a new urgency. This webinar addresses these questions from the perspective of medical oncology.
Changes to ABIM’s Maintenance of Certification Program
Presented by: Kevin Caviston, Strategic Communications at ABIM
Intended for physicians, this webinar will explain what Maintenance of Certification (MOC) is, why it is required, and how physicians can fulfill the requirements.
Financial Counseling Role-Play: Conversations with Patients and Caregivers
Presented by: Catherine Credeur, LMSW, OSW-C, UT Southwestern Medical Center and John Hennessy, Sarah Cannon Cancer Center
This webinar focused on the financial counseling work we all do in our daily lives. The presenters introduced role-playing as a means of preparing for difficult financial conversations. The role-play scenarios provided in this program can be applied in daily practice to help with the financial challenges patients face.
New Strategies in Melanoma: Molecular Testing
Presented by: Amit Jain, MD, MPH, Tallahassee Memorial Healthcare Hematology and Cancer Specialists, FSU College of Medicine
This presentation focused on the efficacy and use of molecular markers in the treatment of melanoma. This program was sponsored through a grant provided by Bristol-Myers Squibb.